Gene Query: ATP6V1F

Dataset Description Geneva Score
BET bromodomain inhibition 62.97
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 62.97
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 34.42
A transcriptome-wide divergence in protein translation scales with LIN28B expression 32.89
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 29.97
EWSR1 influences alternative splicing through direct and indirect mechanisms 29.21
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 25.81
hTERT promotes cell adhesion and migration independent of telomerase activity 22.36
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 21.94
Identification of transcription start sites for human A549 cell line using ReCappable-seq 21.69
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 21.52
LncRNA expression profiling of ischemic stroke patients 20.35
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 20.09
Lipid degradation promotes prostate cancer cell survival 20.05
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 19.91
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 19.91
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 19.86
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 19.09
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 19.07
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 18.66
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 18.66
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 18.53
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 18.37
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.88
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 17.38
MOF acetyl transferase regulates transcription and respiration in mitochondria 16.93
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 16.83
Impact of dieldrin on transcription in Jurkat T cells 16.7
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 16.01
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.85
Global analysis of enhancer targets: Mosaic-seq 15.8
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 15.74
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 15.71
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 14.85
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 14.85
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.74
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 14.55
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.42
The comparison of high-throughput single-cell RNA-seq methods 14.29
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 14.15
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 13.86
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 13.7
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 13.69
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 13.55
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 13.28
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 13.21
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 12.98
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 12.97
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 12.95
Systematic discovery of endogenous human ribonucleoprotein complexes 12.79
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 12.73
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 12.73
Differential analysis of gene regulation at transcript resolution by RNA-Seq 12.73
Transcriptional profiling of microglia; current state of the art and future perspectives 12.67
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.64
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 12.63
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 12.6
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 12.47
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 12.44
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 12.39
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.21
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.21
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 12.11
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 12.04
Stem and effector CD8 T-cells from human cancers 11.99
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.95
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 11.94
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 11.94
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 11.79
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 11.7
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.53
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 11.37
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 10.87
Genes significantly down or Up-regulated upon RNF219 knockdown 10.82
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 10.71
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 10.62
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 10.62
Effect of PRDM11 depletion in U2932 cells 10.6
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.49
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 10.47
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 10.47
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 10.41
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 10.4
CROP-Seq in Primary Human T Cells 10.27
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 10.25
Cajal bodies are linked to genome conformation [RNA-Seq] 10.23
Cajal bodies are linked to genome conformation 10.23
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 10.19
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 10.13
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 10.11
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 10.1
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 10.03
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 9.94
Transcription elongation regulates genome 3D structure 9.88
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.88
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 9.8
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 9.76
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.72
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 9.62
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.6
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.55
Effect of FGF13 depletion on the H460 cell line 9.52
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.46
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 9.45
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.44
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.43
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 9.15
RNA-sequencing of healthy human skeletal myocytes 9.13
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 9.12
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.12
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 9.11
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 9.05
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.02
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.02
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.98
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.98
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 8.95
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 8.8
HEK293 Heat-shock experiment 8.79
scRNASeq analysis of cycling cardiomyocytes 8.75
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 8.75
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 8.7
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.67
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.63
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 8.63
Gene expression changes caused by KRAS in MCF-10A 8.49
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 8.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 8.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 8.37
Accurate annotation of human protein-coding small open reading frames 8.35
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.35
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.32
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 8.24
Lysine benzoylation is a novel histone mark 8.23
Lysine benzoylation is a novel histone mark [RNA-seq] 8.23
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 8.23
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.22
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 8.21
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 8.21
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 8.2
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 8.07
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 7.95
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 7.91
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 7.83
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 7.83
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 7.82
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 7.79
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 7.79
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 7.78
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 7.75
RNA editing in nascent RNA affects pre-mRNA splicing 7.71
Effect of CHKA knockdown on C4-2 cell transcriptome 7.7
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.7
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.7
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.68
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 7.68
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.63
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.63
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 7.62
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 7.59
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 7.59
Differential gene expression profiles in imatinib-resistant cell lines 7.58
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 7.57
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.57
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 7.57
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 7.57
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 7.57
Regulation of highly expressed hCINAP on translatome 7.54
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 7.51
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 7.5
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 7.49
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.49
BCL11B 7.49
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.47
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.47
3’ Uridylation Expands miRNA Target Repertoire 7.41
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.41
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.41
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 7.31
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 7.29
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 7.29
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.27
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 7.2
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.19
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 7.17
RNA-seq analysis of the human fetal kidney. 7.14
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.08
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 7.06
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.03
Pharmacologic inhibition of STAT5 in AML 7.0
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.99
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.99
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.93
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.93
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 6.88
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.85
Generation and functional characterization of MDSC-like cells 6.76
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 6.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 6.74
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.73
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.73
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.72
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.72
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.66
Noncoding regions are the main source of targetable tumor-specific antigens 6.63
miR941 overexpression experiment 6.57
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 6.55
Identification of renal resident macrophages across species 6.54
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 6.53
Transcriptome analysis of peripheral blood monocytes 6.42
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 6.41
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.35
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.31
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.29
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.28
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 6.25
Trans-differentiation of human adult peripheral blood T cells into neurons 6.25
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.21
ARID1A regulates condensin II distribution and chromosomal partition 6.18
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.18
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 6.09
The effect of insulin on mRNA transcription of human pluripotent stem cells 6.09
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.08
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.07
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.01
RNA-seq of shEZH2 cells 5.99
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.96
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 5.91
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 5.89
Direct Isolation and Characterization of Human Nephron Progenitors. 5.88
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 5.86
Gene expression profiling of leukemia cells following asparagine depletion 5.84
Targeting MTHFD2 in Acute Myeloid Leukemia 5.82
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.76
MCF-7 as a model for functional analysis of breast cancer risk variants 5.75
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.71
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 5.68
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 5.66
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.61
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 5.6
DAOY-Notch1/Notch2 knockout: transcriptome comparison 5.52
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.49
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.49
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 5.45
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.43
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.38
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.38
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.38
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 5.37
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.35
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.34
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.34
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 5.29
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.28
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 5.26
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.21
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 5.18
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 5.15
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.07
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.07
RNAseq of cell lines with knocked in ESR1 mutations 5.04
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.03
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 5.03
In situ CAPTURE of chromatin interactions by biotinylated dCas9 5.0
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 5.0
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.98
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.97
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 4.97
Identification of long noncoding RNAs regulated by p53 4.96
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.95
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.95
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.95
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.94
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.91
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 4.9
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.86
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.86
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.84
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 4.83
Transcriptomic analysis of the HOTAIR-regulated genes 4.81
RNA-seq of naive and primed ES cells (NHSM) 4.8
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.74
Activity-dependent transcriptional changes in human neurons 4.73
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.73
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.71
Dynamic 3D chromosomal landscapes in acute leukemia 4.71
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 4.68
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.67
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 4.67
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 4.63
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.63
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.6
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.57
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.54
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.49
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 4.37
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.32
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 4.27
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.24
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.24
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 4.22
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 4.2
Regulatory network controlling tumor-promoting inflammation in human cancers 4.2
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 4.18
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.16
Modeling Human Cancer-induced Cachexia (Human) 4.14
RNA-seq differential expression studies: more sequence, or more replication? 4.14
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.13
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.02
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 4.01
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.99
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 3.99
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.95
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.95
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 3.94
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.92
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.87
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  3.78
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 3.78
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.77
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.77
Functional significance of the HIV-1 Tat signature amino acid residues 3.75
Fibroblasts in cholesteatoma activate osteoclasts. 3.73
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.7
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.7
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.69
Gene expression analysis upon mtDNA depletion 3.65
Gene expression analysis upon mtDNA depletion [RNA-seq] 3.65
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.62
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 3.62
IMP3 regulated gene expression in breast cancer cells 3.62
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.59
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.59
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.59
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.57
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.45
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 3.43
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 3.43
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.38
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.38
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.37
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.35
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.34
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.34
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.32
RNA-seq of RKO cells with cTAZ KO or putback 3.31
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 3.28
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 3.26
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.24
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.24
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 3.21
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.15
Loss of CREBBP results in gene expression repression in lymphoma cells 3.15
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 3.05
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.04
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.04
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.02
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.02
Comparative Analysis of Cas9 Activators Across Multiple Species 3.01
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.0
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 2.99
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.92
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.92
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.9
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.86
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.85
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.84
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.84
Transcriptomes of oxLDL exposed trained monocytes 2.84
oxLDL exposed trained monocytes 2.84
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.83
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.83
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.83
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.8
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.8
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.76
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.76
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.75
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.72
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.71
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.7
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 2.69
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.64
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.54
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.51
The bromodomain protein BRD4 regulates splicing during heat shock 2.5
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.46
MicroRNA-125a-5p overexpression in human macrophages 2.43
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.42
Single-cell analysis of human kidney organoids 2.41
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.41
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.41
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.39
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.34
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.3
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.3
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.25
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.24
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.23
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.23
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.23
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.22
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.22
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.22
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.2
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.06
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.06
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.04
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.04
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.0
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 1.96
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 1.96
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.91
MAIT cell RNA sequencing 1.89
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.88
Identification of renal resident macrophages across species [C1] 1.83
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.79
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.75
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.75
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.74
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.72
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.7
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.68
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.68
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.66
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.61
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.6
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.59
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.56
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.48
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.47
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.47
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.45
Dermal endothelial cells of type 2 diabetic patients 1.42
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.35
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.29
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.25
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.2
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.2
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.2
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.1
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.09
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.09
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.05
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.97
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.96
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.96
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.96
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 0.9
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.8
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.8
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.8
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.74
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.74
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.66
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.65
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.63
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.61
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.56
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.52
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.48
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.48
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 0.47
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 0.47
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.45
Induced DNA demethylation, genome instability and transcription 0.44
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.44
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.43
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.36
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.33
Anti-inflammatory effect of indoleacrylic acid (IA) 0.32
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.27
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.27
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.26
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.24
ZIKV infection of monocytes activates inflammasome pathways 0.22
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.21
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.2
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.14
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.13
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.13
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.12
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.12
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.11
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.1
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.1
Tpl-2 and MEK small molecule inhibitors 0.06
Tpl-2 small molecule project 0.06
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.06
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.03
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.02
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.02
MHC Transcriptomic landscape at haplotype-specific resolution 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation